The primary manifestation of the antiphospholipid antibody syndrome (APS) is thrombosis, which forms the core of the classification criteria for this syndrome. However, multiple other noncriteria ...

Arterial thrombosis, venous thrombosis and morbidity during pregnancy, or a combination of these events, are clinical outcomes associated with antiphospholipid antibodies produced by patients with ...

The antiphospholipid syndrome (APS) is an autoimmune, multisystemic disorder associated with recurrent thrombosis (arterial and/or venous) and pregnancy loss, among other clinical manifestations. The ...

Antiphospholipid syndrome is an autoimmune connective tissue disease characterized by vascular thrombosis and pregnancy morbidity in the presence of antiphospholipid antibodies, namely lupus ...

Please provide your email address to receive an email when new articles are posted on . This is the first classification criteria revision for antiphospholipid syndrome since 2006. The new guidelines ...

Although thrombosis is considered the cardinal feature of the antiphospholipid syndrome, chronic vascular lesions are common, particularly in patients with life-threatening complications. In patients ...

Unexplained chorea, especially among women, should prompt testing for antibodies associated with antiphospholipid syndrome, according to data published in Lupus Science & Medicine. SAN DIEGO — ...

APS is a systemic autoimmune disease associated with persistent antiphospholipid antibodies (aPL). It can cause thrombosis and pregnancy complications as well as non-thrombotic manifestations such as ...

Researchers studying antiphospholipid syndrome (APS) found that patients with the disease have high levels of bacteria that make phospholipids. It has been previously established that antiphospholipid ...

The ongoing research and scientific debate on pathophysiology, classification, nomenclature and diagnosis of antiphospholipid syndrome illustrates the complexity of cellular membranes, their dynamic ...

The Geneva University Hospitals (HUG), the University of Geneva (UNIGE) and their spin-off Endotelix have created the best possible target molecule for the antibodies responsible for antiphospholipid ...

HOUSTON — Antiphospholipid antibodies were associated with the presence of food allergies, according to study results presented at the 2019 Annual Meeting of the American College of Asthma, Allergy, ...